THBD and peripheral neuropathy: Tsubota et al. indicated that anticoagulant (argatroban) could promote bortezomib-induced peripheral neuropathy (BIPN) and cancel the anti-BIPN effect of recombinant thrombomodulin (Tsubota et al., 2021).